Possible GI Malignancy in a Man with Weight Loss and Microcytic Anaemia

This man is experiencing weight loss and has an unexplained microcytic anaemia. The most probable cause of his blood loss is from the gastrointestinal (GI) tract, as there is no other apparent explanation. This could be due to an occult GI malignancy, which is why the recommended initial investigations are upper and lower GI endoscopy. These tests will help to identify any potential sources of bleeding in the GI tract and determine if there is an underlying malignancy. It is important to diagnose and treat any potential malignancy as early as possible to improve the patient’s prognosis. Therefore, prompt investigation and management are crucial in this case.

The patient is experiencing a worsening of their Crohn’s disease, likely due to poor medication compliance. Symptoms include bloody bowel movements, fatigue, and elevated inflammatory markers. Admission to a Medical Ward for IV hydration, electrolyte replacement, and corticosteroids is necessary as the patient is systemically unwell. Stool microscopy, culture, and sensitivity should be performed to rule out any infectious causes. Azathioprine has been prescribed but has caused side-effects and takes too long to take effect. Immediate surgery is not necessary as the patient has stable observations and a soft abdomen. Infliximab is an option for severe cases but requires screening for tuberculosis. Oral steroids may be considered for mild cases, but given the patient’s non-compliance and current presentation, they are not suitable.

The Importance of Endoscopy in Diagnosing and Treating Upper GI Bleeds

When a patient presents with an upper GI bleed, it is important to determine the cause and provide appropriate treatment. In cases where the bleed is likely caused by a duodenal ulcer from non-steroidal anti-inflammatory drug use, an OGD (oesophago-gastro-duodenoscopy) is necessary for diagnosis and initial therapeutic management. Endoscopy allows for the identification of a bleeding ulcer, which can then be injected with adrenaline and clipped to prevent re-bleeding.

Continued transfusion may help resuscitate the patient, but it will not stop the bleeding. A CT scan with embolisation could be useful, but a CT scan alone would not be sufficient. Laparotomy should only be considered if endoscopic therapy fails. Diagnostic laparoscopy is not necessary as a clinical diagnosis can be made based on the patient’s history and condition.

In conclusion, endoscopy is crucial in diagnosing and treating upper GI bleeds, particularly in cases where a duodenal ulcer is suspected. It allows for immediate intervention to stop the bleeding and prevent further complications.

Understanding Liver Function Tests: Indicators of Synthetic and Parenchymal Function

Liver function tests are crucial in determining the nature of any liver impairment. The liver is responsible for producing vitamin K and albumin, and any dysfunction can lead to an increase in prothrombin time, indicating acute synthetic function. Albumin, on the other hand, provides an indication of synthetic liver function over a longer period due to its half-life of 20 days in serum.

While prothrombin time is a reliable indicator, alkaline phosphatase (ALP) would be raised in obstructive (cholestatic) disease. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) represent liver parenchymal function, rather than synthetic function. It’s important to note that both can be normal despite significantly decreased synthetic function of the liver.

While albumin does give an indication of liver function, it can be influenced by many other factors. ALP, on the other hand, would be raised in cholestatic disease. It’s important to consider all these factors when interpreting liver function tests, as neither ALT nor ALP would indicate synthetic function of the liver.

Crohn’s Disease

Crohn’s disease is a condition that affects different parts of the digestive tract. The location of the disease can be classified as ileal, colonic, ileo-colonic, or upper gastrointestinal tract. In some cases, the disease can cause a solid, thickened mass around the caecum, which also involves the terminal ileum. This is known as ileo-colonic Crohn’s disease.

While weight loss is a common symptom of Crohn’s disease, it is not always present. It is important to note that the range of areas affected by the disease makes it unlikely for it to be classified as anything other than ileo-colonic Crohn’s disease.

Understanding Wilson’s Disease: Symptoms, Diagnosis, and Treatment

Wilson’s disease is a rare genetic disorder that causes copper to accumulate in the liver and brain, leading to a range of symptoms including neuropsychiatric issues, liver disease, and parkinsonism. Diagnosis is typically based on low serum ceruloplasmin and low serum copper, as well as the presence of Kayser-Fleischer rings in the cornea. Treatment involves a low copper diet and the use of copper chelators like penicillamine, with liver transplant as a potential option for severe cases. Other conditions, such as α-1-antitrypsin deficiency and autoimmune hepatitis, can cause liver disease but do not typically present with parkinsonian symptoms. Understanding the unique features of Wilson’s disease is crucial for accurate diagnosis and effective treatment.

Gallstones are formed in the gallbladder from bile constituents. In Europe and the Americas, they can be made of pure cholesterol, bilirubin, or a mixture of both. Mixed stones, also known as brown pigment stones, usually contain 20-80% cholesterol. Uric acid is not typically found in gallstones unless the patient has gout. Palmitate is a component of gallstones, but cholesterol is the primary constituent. Increased bilirubin production, such as in haemolysis, can cause bile pigment stones, which are most commonly seen in patients with haemolytic anaemia or sickle-cell disease. Calcium is a frequent component of gallstones, making them visible on radiographs, but cholesterol is the most common constituent.

Angiodysplasia

Angiodysplasia is a condition where previously healthy blood vessels degenerate, commonly found in the caecum and proximal ascending colon. The majority of angiodysplasias, around 77%, are located in these areas. Symptoms of angiodysplasia include maroon-coloured stool, melaena, haematochezia, and haematemesis. Bleeding is usually low-grade, but in some cases, around 15%, it can be massive. However, bleeding stops spontaneously in over 90% of cases.

Radionuclide scanning using technetium Tc99 labelled red blood cells can help detect and locate active bleeding from angiodysplasia, even at low rates of 0.1 ml/min. However, the intermittent nature of bleeding in angiodysplasia limits the usefulness of this method. For patients who are haemodynamically stable, a conservative approach is recommended as most bleeding angiodysplasias will stop on their own. Treatment is usually not necessary for asymptomatic patients who incidentally discover they have angiodysplasias.

Overall, angiodysplasia and its symptoms is important for early detection and management.

Anatomical Landmarks and their Surface Markings in the Abdomen

The human abdomen is a complex region with various structures and organs that are important for digestion and metabolism. In this article, we will discuss some of the anatomical landmarks and their surface markings in the abdomen.

Surface Marking: Lateral edge of right rectus abdominis muscle and the costal margin
Anatomical Landmark: Fundus of the gallbladder

The fundus of the gallbladder is located closest to the anterior abdominal wall. Its surface marking is the point where the lateral edge of the right rectus abdominis muscle meets the costal margin, which is also in the transpyloric plane. It is important to note that Courvoisier’s law exists in surgery, which states that a palpable, enlarged gallbladder accompanied by painless jaundice is unlikely to be caused by gallstone disease.

Surface Marking: Anterior axillary line and the transpyloric plane
Anatomical Landmark: Hilum of the spleen

The transpyloric plane is an imaginary line that runs axially approximately at the L1 vertebral body. The hilum of the spleen can be found at the intersection of the anterior axillary line and the transpyloric plane.

Surface Marking: Linea alba and the transpyloric plane
Anatomical Landmark: Origin of the superior mesenteric artery

The origin of the superior mesenteric artery can be found at the intersection of the linea alba and the transpyloric plane.

Surface Marking: Mid-clavicular line and the transpyloric plane
Anatomical Landmark: Hepatic flexure of the colon on the right and splenic flexure of the colon on the left

At the intersection of the mid-clavicular line and the transpyloric plane, the hepatic flexure of the colon can be found on the right and the splenic flexure of the colon on the left.

Surface Marking: Mid-clavicular line and a horizontal line through the umbilicus
Anatomical Landmark: Ascending colon on the right and descending colon on the left

At the intersection of the mid-clavicular line and a horizontal line through the umbilicus, the ascending colon is found on the right and the descending colon on the left. If the liver or spleen are enlarged, their tips can also

Common Disease-Modifying Agents and Their Targets

Disease-modifying agents (DMARDs) are a group of drugs used to treat various diseases, including rheumatic disease, gastrointestinal disease, and neurological conditions. These agents have different targets in the immune system, and some of the most common ones are discussed below.

Antibody against Tumour Necrosis Factor-alpha (TNF-α)
TNF-α inhibitors, such as infliximab and adalimumab, are used to treat rheumatic disease and inflammatory bowel disease. These agents increase susceptibility to infection and should not be administered with live vaccines.

Antibody against CD20
Rituximab is a monoclonal antibody against CD20 and is used to treat aggressive non-Hodgkin’s lymphoma.

Interleukin (IL)-1 Blocker
Anakinra is an IL-1 receptor antagonist used to treat rheumatoid arthritis.

α-4 Integrin Antagonist
Natalizumab is a humanised monoclonal antibody against α-4-integrin and is used to treat multiple sclerosis.

IL-2 Blocker
Daclizumab is a monoclonal antibody that binds to the IL-2 receptor and is used to prevent acute rejection following renal transplantation.

Targets of Disease-Modifying Agents